Glenmede Trust’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $547K | Buy |
8,683
+2,042
| +31% | +$143K | ﹤0.01% | 958 |
|
|
2026
Q1 | $501K | Buy |
6,641
+112
| +2% | +$7.99K | ﹤0.01% | 960 |
|
|
2025
Q4 | $403K | Buy |
+6,529
| New | +$384K | ﹤0.01% | 1018 |
|
|
2025
Q1 | $249K | Buy |
+5,009
| New | +$256K | ﹤0.01% | 1146 |
|
|
2024
Q4 | – | Sell |
-6,634
| Closed | -$319K | – | 1440 |
|
|
2024
Q3 | $319K | Sell |
6,634
-144
| -2% | -$6.94K | ﹤0.01% | 1077 |
|
|
2024
Q2 | $345K | Sell |
6,778
-221
| -3% | -$12.1K | ﹤0.01% | 1010 |
|
|
2024
Q1 | $380K | Sell |
6,999
-94
| -1% | -$4.9K | ﹤0.01% | 998 |
|
|
2023
Q4 | $400K | Sell |
7,093
-4,521
| -39% | -$255K | ﹤0.01% | 963 |
|
|
2023
Q3 | $717K | Buy |
11,614
+2,923
| +34% | +$185K | ﹤0.01% | 728 |
|
|
2023
Q2 | $642K | Hold |
8,691
| – | – | ﹤0.01% | 767 |
|
|
2023
Q1 | $642K | Sell |
8,691
-916
| -10% | -$70.7K | ﹤0.01% | 769 |
|
|
2022
Q4 | $702K | Sell |
9,607
-766
| -7% | -$60.5K | ﹤0.01% | 744 |
|
|
2022
Q3 | $863K | Buy |
10,373
+1,306
| +14% | +$112K | 0.01% | 683 |
|
|
2022
Q2 | $721K | Sell |
9,067
-132
| -1% | -$12.8K | ﹤0.01% | 757 |
|
|
2022
Q1 | $956K | Sell |
9,199
-2,119
| -19% | -$176K | ﹤0.01% | 734 |
|
|
2021
Q4 | $850K | Buy |
11,318
+1,262
| +13% | +$88.3K | ﹤0.01% | 787 |
|
|
2021
Q3 | $651K | Hold |
10,056
| – | – | ﹤0.01% | 825 |
|
|
2021
Q2 | $608K | Sell |
10,056
-480
| -5% | -$28.4K | ﹤0.01% | 828 |
|
|
2021
Q1 | $566K | Buy |
10,536
+1,492
| +16% | +$81.1K | ﹤0.01% | 812 |
|
|
2020
Q4 | $434K | Sell |
9,044
-574
| -6% | -$25.4K | ﹤0.01% | 872 |
|
|
2020
Q3 | $376K | Sell |
9,618
-505
| -5% | -$18.4K | ﹤0.01% | 867 |
|
|
2020
Q2 | $324K | Sell |
10,123
-6,479
| -39% | -$225K | ﹤0.01% | 883 |
|
|
2020
Q1 | $794K | Hold |
16,602
| – | – | ﹤0.01% | 787 |
|
|
2019
Q4 | $794K | Sell |
16,602
-132
| -0.8% | -$6.38K | ﹤0.01% | 787 |
|
|
2019
Q3 | $834K | Buy |
16,734
+726
| +5% | +$37K | ﹤0.01% | 772 |
|
|
2019
Q2 | $855K | Sell |
16,008
-384
| -2% | -$20K | ﹤0.01% | 777 |
|
|
2019
Q1 | $864K | Buy |
16,392
+3,850
| +31% | +$201K | ﹤0.01% | 767 |
|
|
2018
Q4 | $589K | Buy |
12,542
+1,103
| +10% | +$57.5K | ﹤0.01% | 828 |
|
|
2018
Q3 | $659K | Buy |
11,439
+150
| +1% | +$8.3K | ﹤0.01% | 834 |
|
|
2018
Q2 | $614K | Buy |
+11,289
| New | +$560K | ﹤0.01% | 796 |
|
Other funds holding NTR
Glenmede Trust's NTR Position: Q2 2026 in Review
Glenmede Trust increased its Nutrien (NTR) stake by 31% in Q2 2026, buying an estimated $143K and bringing the position to 8,683 shares worth $547K. The position accounts for ﹤0.01% of the portfolio, ranked #958.
Glenmede Trust first reported a position in NTR in Q2 2018 and has held it in 30 quarters since. The position peaked at $956K in Q1 2022. 736 funds tracked by Wall St. Rank hold NTR as of Q2 2026.
- Glenmede Trust held 8,683 shares of Nutrien worth $547K as of Q2 2026.
- Glenmede Trust bought 2,042 Nutrien shares in Q2 2026, an estimated $143K.
- Nutrien made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #958 holding.
- Glenmede Trust first reported a position in Nutrien in Q2 2018 and has held it in 30 quarters since.
- Glenmede Trust's Nutrien position peaked at $956K in Q1 2022.
- 736 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.
Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.